$1,349.00 Original price was: $1,349.00.$130.00Current price is: $130.00.
This course provides a thorough review and update of the pathologic diagnosis and clinical significance of benign, in situ, and malignant lesions of the breast identified in surgical specimens and core needle biopsies. The most current adjunctive immunohistochemical and molecular studies to assist in the diagnosis and classification of benign and malignant breast lesions, as well as guide patient management, are emphasized.
Upon completion of this educational activity, learners will be able to:
After participating in this educational initiative, attendees will achieve the following learning objectives:
Articulate the diagnostic criteria and clinical significance associated with a diverse array of benign, in situ, and malignant breast lesions frequently encountered in surgical specimens and core needle biopsies.
Engage in discussions regarding diagnostic challenges commonly encountered in breast pathology. Comprehend the utility and constraints of supplementary immunohistochemical and molecular assays in facilitating precise diagnoses.
Delve into the realm of prognostic and predictive assays applicable to patients afflicted with breast cancer. Gain proficiency in interpreting these assays, which play a crucial role in guiding treatment decisions.
This educational course is an indispensable platform for clinicians, pathologists, and researchers seeking to augment their grasp of contemporary issues in breast pathology. By integrating cutting-edge knowledge and practical methodologies, participants will be well-equipped to address diagnostic uncertainties and contribute to optimal patient care.
Original Release Date: July 8, 2023
Author |
---|
Fermentum tempor cubilia risus tellus massa dis consectetur dolor.
WhatsApp Chat Oniline